League of Legends team owner embroiled in drug price hike controversy
A League of Legends eSports team owner has found himself mired in controversy after acquiring the rights to a drug used to treat bacterial infections for more than 60 years.
LoL fan Martin "Cerebral" Shkreli, an ex-hedge fund manager turned pharmaceutical CEO, created the competitive team Odyssey earlier this year.
The team was merged with another, Team Imagine, soon after. Imagine has achieved some success since the merger, reaching the semi-finals of this year's NACS Summer Playoffs.
from Eurogamer.net http://ift.tt/1L2vn7j
تعليقات
إرسال تعليق